Novel Patient with Late-Onset Familial Hemophagocytic Lymphohistiocytosis with STXBP2 Mutations Presenting with Autoimmune Hepatitis, Neurological Manifestations and Infections Associated with Hypogammaglobulinemia
Astute Clinician Report
First Online:
Received:
Accepted:
- 467 Downloads
- 1 Citations
Abstract
Familial hemophagocytic lymphohistiocytosis (FHL) is a genetically heterogeneous hyperinflammatory syndrome, caused by an uncontrolled and ineffective proliferation and activation of T-lymphocytes, NK-cells, and macrophages that infiltrate multiple organs. Herein, a patient is presented who suffered from hepatitis and atypical brain lesions. Genetic studies revealed a homozygous mutation in the STXP2 gene; and thus, the diagnosis of FHL5 was confirmed.
Keywords
Familial hemophagocytic lymphohistiocytosis STXBP2 brain lesions autoimmune hepatitisNotes
Conflicts of Interest
The authors declare no conflict of interest.
References
- 1.Shamsian BS, Rezaei N, Alavi S, et al. Primary hemophagocytic lymphohistiocytosis in Iran: Report from a single referral center. Pediatr Hematol Oncol. 2012;29(3):215–9.PubMedCrossRefGoogle Scholar
- 2.Filipovich AH. Hemophagocytic lymphohistiocytosis and other hemophagocytic disorders. Immunol Allergy Clin North Am. 2008;28(2):293–313.PubMedCrossRefGoogle Scholar
- 3.Henter JI, Horne A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guideline for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.PubMedCrossRefGoogle Scholar
- 4.Pagel J, Beutel K, Lehmberg K. Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lmphohistiocytosis type 5 (FHL5). Blood. 2012;119(25):6016–24.PubMedCrossRefGoogle Scholar
- 5.Gholam C, Grigoriadou S, Gilmour C, et al. Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management. Clin Exp Immunol. 2011;163:271–83.PubMedCentralPubMedCrossRefGoogle Scholar
- 6.Dehkordy SF, Aghamohammadi A, Ochs HD, Rezaei N. Primary immunodeficiency diseases associated with neurologic manifestations. J Clin Immunol. 2012;32(1):1–24.PubMedCrossRefGoogle Scholar
- 7.Deiva K, Mahlaoui N, Beaudonnet F, et al. CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis. Neurology. 2012;78(15):1150–6.PubMedCrossRefGoogle Scholar
- 8.zur Stadt U, Rohr J, Seifert W. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet. 2009;85(4):482–92.PubMedCentralPubMedCrossRefGoogle Scholar
- 9.Côte M, Ménager MM, Burgess A, et al. Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest. 2009;119(12):3765–73.PubMedCentralPubMedCrossRefGoogle Scholar
- 10.Bryceson YT, Pende D, Pavicic AM, Gilmour KC, et al. A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. Blood. 2012;119:2754–63.PubMedCrossRefGoogle Scholar
- 11.Rohr J, Beutel K, Maul-Pavicic A, et al. Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases. Haematologica. 2010;95(12):2080–7.PubMedCentralPubMedCrossRefGoogle Scholar
- 12.Meeths M, Entesarian M, Al-Herz W, et al. Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2. Blood. 2010;116(15):2635–43.PubMedCrossRefGoogle Scholar
Copyright information
© Springer Science+Business Media New York 2014